Aura Biosciences
Clinical trials sponsored by Aura Biosciences, explained in plain language.
-
New shot for eye tumors shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called belzupacap sarotalocan (AU-011) for people whose cancer has spread to the back of the eye (the choroid). The drug is given as an injection near the eye. The main goals are to check safety and see if it shrinks the tumor. About 24 adults with thi…
Phase: PHASE2 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
Light-Activated drug could halt rare eye cancer growth
Disease control Recruiting nowThis study tests a new drug called belzupacap sarotalocan (AU-011) for people with a rare eye cancer (choroidal melanoma) or suspicious spots that could turn into cancer. The drug is activated by a laser to target and destroy cancer cells. About 100 participants will receive eith…
Phase: PHASE3 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
New shot for bladder tumors shows promise in early trial
Disease control Recruiting nowThis early-stage study is testing a new drug, belzupacap sarotalocan, injected directly into bladder tumors to see if it's safe and doable for people with non-muscle-invasive bladder cancer. About 55 participants will receive the injection, sometimes with a laser, and be monitore…
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
Eye cancer Patients' Well-Being under the microscope
Knowledge-focused Recruiting nowThis study looks at how choroidal melanoma and its treatment affect daily life and well-being. It involves 15 people already in a larger Phase 3 trial. Participants fill out questionnaires about their quality of life over two years. No new drugs or procedures are tested here.
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC